Question 74

Patients who have congestive heart failure should be cautious when taking pregabalin because the medication has been associated with peripheral edema.

Pregabalin has been linked to the occurrence of peripheral edema, which is a significant concern for patients with congestive heart failure as it can exacerbate their condition.

A) serotonin syndrome.

Serotonin syndrome is a potentially life-threatening condition associated with increased serotonin levels, typically linked to the use of certain antidepressants and not directly to pregabalin. Therefore, this option is incorrect as it does not relate to the known side effects of pregabalin.

B) peripheral edema.

Peripheral edema is indeed a documented side effect of pregabalin. In patients with congestive heart failure, this can lead to worsening symptoms and increased fluid retention, making this option the correct answer.

C) hyperglycemia.

While some medications can affect blood sugar levels, pregabalin is not primarily associated with hyperglycemia. This makes this option incorrect as it does not align with the known effects of pregabalin on patients with heart conditions.

D) weight loss.

Pregabalin is not typically associated with weight loss; in fact, it can sometimes lead to weight gain due to fluid retention. Thus, this option is incorrect as it does not reflect the side effects relevant to the medication's use in congestive heart failure patients.

Conclusion

The correct answer, peripheral edema, is particularly critical for patients with congestive heart failure as it can lead to further complications and worsening of their condition. The other options do not align with the known side effects of pregabalin, emphasizing the importance of understanding the specific risks associated with this medication in vulnerable populations.